Ultimovacs is a leading biopharmaceutical company focused on the development, manufacturing and distribution of immune-activated vaccines. We are committed to bringing innovative, safe and effective vaccine solutions to patients around the world.

History

Ultimovacs was founded in 2018 with one mission: to create revolutionary immune-activated vaccines that are safe, effective and accessible to all. We invest considerable resources into the research and development of our products, which have become some of the most widely used and accepted products in the industry.

Mission

Our mission at Ultimovacs is to revolutionize vaccinology and make life-saving vaccines accessible to everyone. We are committed to providing our customers with the most innovative and reliable vaccine solutions to meet the needs of the global population.

Vision

At Ultimovacs, our vision is to provide the world with a greater number of safe and effective vaccines that have the potential to help people live healthier and longer lives.

Key Team

Øyvind K. Arnesen (Founder)

Recognition and Awards

Ultimovacs has received numerous awards and recognitions from industry organizations, including the Solvay Innovation Award, the Global Citizen Award, the World Bank BioVaccinology Award and the World Vaccines Alliance World Vaccine Excellence Award.

References

https://www.crunchbase.com/organization/ultimovacs

ultimovacs.com/

Dive deeper into fresh insights across Business, Industry Leaders and Influencers, Organizations, Education, and Investors for a comprehensive view.

Leadership team

Øyvind K. Arnesen (Founder)

Products/ Services

Biotechnology, Health Care, Pharmaceutical

Number of Employees

0 - 50

Headquarters

Oslo, Oslo, Norway

Established

2011

Company Registration

SEC CIK number: 0001016125

Traded as

OSE:ULTI

Social Media

URL

ultimovacs.com/

Last updated: Tue Feb 25 2025

We value your privacy

Ultimovacs

Table of content

Summary